Vitamin D and cardiovascular health
Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved..
The principal source of vitamin D in humans is its biosynthesis in the skin through a chemical reaction dependent on sun exposure. In lesser amounts, the vitamin can be obtained from the diet, mostly from fatty fish, fish liver oil and mushrooms. Individuals with vitamin D deficiency, defined as a serum level of 25 hydroxyvitamin D < 20 ng/dl, should be supplemented. Vitamin D deficiency is a prevalent global problem caused mainly by low exposure to sunlight. The main role of 1,25 dihydroxyvitamin D is the maintenance of calcium and phosphorus homeostasis. However, vitamin D receptors are found in most human cells and tissues, indicating many extra-skeletal effects of the vitamin, particularly in the immune and cardiovascular (CV) systems. Vitamin D regulates blood pressure by acting on endothelial cells and smooth muscle cells. Its deficiency has been associated with various CV risk factors and appears to be linked to a higher mortality and incidence of CV disease (CVD). Several mechanisms have been proposed relating vitamin D deficiency to CV risk factors such as renin-angiotensin-aldosterone system activation, abnormal nitric oxide regulation, oxidative stress or altered inflammatory pathways. However, in the latest randomized controlled trials no benefits of vitamin D supplementation for CVD have been confirmed. Although more work is needed to establish the protective role of vitamin D in this setting, according to current evidences vitamin D supplements should not be recommended for CVD prevention.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
Clinical nutrition (Edinburgh, Scotland) - 40(2021), 5 vom: 15. Mai, Seite 2946-2957 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
de la Guía-Galipienso, Fernando [VerfasserIn] |
---|
Links: |
---|
Themen: |
1406-16-2 |
---|
Anmerkungen: |
Date Completed 31.08.2021 Date Revised 21.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.clnu.2020.12.025 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM319615340 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM319615340 | ||
003 | DE-627 | ||
005 | 20231225171828.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.clnu.2020.12.025 |2 doi | |
028 | 5 | 2 | |a pubmed24n1065.xml |
035 | |a (DE-627)NLM319615340 | ||
035 | |a (NLM)33397599 | ||
035 | |a (PII)S0261-5614(20)30700-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a de la Guía-Galipienso, Fernando |e verfasserin |4 aut | |
245 | 1 | 0 | |a Vitamin D and cardiovascular health |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 31.08.2021 | ||
500 | |a Date Revised 21.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved. | ||
520 | |a The principal source of vitamin D in humans is its biosynthesis in the skin through a chemical reaction dependent on sun exposure. In lesser amounts, the vitamin can be obtained from the diet, mostly from fatty fish, fish liver oil and mushrooms. Individuals with vitamin D deficiency, defined as a serum level of 25 hydroxyvitamin D < 20 ng/dl, should be supplemented. Vitamin D deficiency is a prevalent global problem caused mainly by low exposure to sunlight. The main role of 1,25 dihydroxyvitamin D is the maintenance of calcium and phosphorus homeostasis. However, vitamin D receptors are found in most human cells and tissues, indicating many extra-skeletal effects of the vitamin, particularly in the immune and cardiovascular (CV) systems. Vitamin D regulates blood pressure by acting on endothelial cells and smooth muscle cells. Its deficiency has been associated with various CV risk factors and appears to be linked to a higher mortality and incidence of CV disease (CVD). Several mechanisms have been proposed relating vitamin D deficiency to CV risk factors such as renin-angiotensin-aldosterone system activation, abnormal nitric oxide regulation, oxidative stress or altered inflammatory pathways. However, in the latest randomized controlled trials no benefits of vitamin D supplementation for CVD have been confirmed. Although more work is needed to establish the protective role of vitamin D in this setting, according to current evidences vitamin D supplements should not be recommended for CVD prevention | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
650 | 4 | |a Cardiovascular disease | |
650 | 4 | |a Coronary heart disease | |
650 | 4 | |a Endothelial function | |
650 | 4 | |a Hypertension | |
650 | 4 | |a Supplements | |
650 | 7 | |a Vitamin D |2 NLM | |
650 | 7 | |a 1406-16-2 |2 NLM | |
700 | 1 | |a Martínez-Ferran, María |e verfasserin |4 aut | |
700 | 1 | |a Vallecillo, Néstor |e verfasserin |4 aut | |
700 | 1 | |a Lavie, Carl J |e verfasserin |4 aut | |
700 | 1 | |a Sanchis-Gomar, Fabian |e verfasserin |4 aut | |
700 | 1 | |a Pareja-Galeano, Helios |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical nutrition (Edinburgh, Scotland) |d 1982 |g 40(2021), 5 vom: 15. Mai, Seite 2946-2957 |w (DE-627)NLM08284366X |x 1532-1983 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2021 |g number:5 |g day:15 |g month:05 |g pages:2946-2957 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clnu.2020.12.025 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 40 |j 2021 |e 5 |b 15 |c 05 |h 2946-2957 |